These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 8108140

  • 1. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 2. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 3. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B, Petmitr S, Ponglikitmongkol M, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Anticancer Res; 2001 Apr; 21(4A):2739-43. PubMed ID: 11724349
    [Abstract] [Full Text] [Related]

  • 4. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 5. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 6. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW.
    Brain Res Mol Brain Res; 2005 Jun 13; 137(1-2):98-103. PubMed ID: 15950766
    [Abstract] [Full Text] [Related]

  • 7. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 13; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 8. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K, Gries H, Bolik E, Cervós-Navarro J, Tschairkin IN, Patt S.
    Histol Histopathol; 1997 Jul 13; 12(3):611-6. PubMed ID: 9225141
    [Abstract] [Full Text] [Related]

  • 9. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K.
    Oncogene; 1991 Aug 13; 6(8):1313-8. PubMed ID: 1886708
    [Abstract] [Full Text] [Related]

  • 10. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 13; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB, Bandea C, Swan D, Abbott K, Varma VA.
    Mod Pathol; 1993 Jul 13; 6(4):442-5. PubMed ID: 8415589
    [Abstract] [Full Text] [Related]

  • 12. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May 13; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 13. TP53 mutations in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Kordek R, Liberski PP.
    Pol J Pathol; 1997 May 13; 48(4):221-4. PubMed ID: 9529927
    [Abstract] [Full Text] [Related]

  • 14. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 15. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 15; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 16. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 15; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 17. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 15; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 18. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 15; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 19. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S, Thorner PS, Ruangvejvorachai P, Saha B, Groshen S, Taylor CR, Malhotra S, Imam SA.
    Neuropathology; 2009 Oct 15; 29(5):521-7. PubMed ID: 19019178
    [Abstract] [Full Text] [Related]

  • 20. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 15; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.